151 related articles for article (PubMed ID: 29520156)
1. Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.
Wang B; Zhang X; Wang W; Zhu Z; Tang F; Wang D; Liu X; Zhuang H; Yan X
Onco Targets Ther; 2018; 11():1067-1075. PubMed ID: 29520156
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
3. Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.
Liu X; Wei X; Niu W; Wang D; Wang B; Zhuang H
Mol Med Rep; 2018 Nov; 18(5):4356-4364. PubMed ID: 30221666
[TBL] [Abstract][Full Text] [Related]
4. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma.
Kong J; Zhang Q; Liang X; Sun W
Open Med (Wars); 2020; 15(1):702-708. PubMed ID: 33313412
[TBL] [Abstract][Full Text] [Related]
5. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
[TBL] [Abstract][Full Text] [Related]
6. FOXK2 suppresses the malignant phenotype and induces apoptosis through inhibition of EGFR in clear-cell renal cell carcinoma.
Zhang F; Ma X; Li H; Zhang Y; Li X; Chen L; Guo G; Gao Y; Gu L; Xie Y; Duan J; Zhang X
Int J Cancer; 2018 Jun; 142(12):2543-2557. PubMed ID: 29368368
[TBL] [Abstract][Full Text] [Related]
7. FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma.
Lin MF; Yang YF; Peng ZP; Zhang MF; Liang JY; Chen W; Liu XH; Zheng YL
Int J Biochem Cell Biol; 2017 Jul; 88():155-161. PubMed ID: 28506857
[TBL] [Abstract][Full Text] [Related]
8. Regulation and roles of FOXK2 in cancer.
Kang Y; Zhang K; Sun L; Zhang Y
Front Oncol; 2022; 12():967625. PubMed ID: 36172141
[TBL] [Abstract][Full Text] [Related]
9. CircUBAP2 Inhibits Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma via Targeting miR-148a-3p/FOXK2 Pathway.
Sun J; Yin A; Zhang W; Lv J; Liang Y; Li H; Li Y; Li X
Cell Transplant; 2020; 29():963689720925751. PubMed ID: 32425115
[TBL] [Abstract][Full Text] [Related]
10. FOXK2 Transcription Factor and Its Emerging Roles in Cancer.
Nestal de Moraes G; Carneiro LDT; Maia RC; Lam EW; Sharrocks AD
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30897782
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer.
Nestal de Moraes G; Khongkow P; Gong C; Yao S; Gomes AR; Ji Z; Kandola N; Delbue D; Man EP; Khoo US; Sharrocks AD; Lam EW
Oncogenesis; 2015 Sep; 4(9):e167. PubMed ID: 26344694
[TBL] [Abstract][Full Text] [Related]
13. Sox9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation.
Qian Y; Xia S; Feng Z
Biochem Biophys Res Commun; 2017 Jan; 483(1):475-481. PubMed ID: 28007600
[TBL] [Abstract][Full Text] [Related]
14. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
15.
Yu Y; Cao WM; Cheng F; Shi Z; Han L; Yi JL; da Silva EM; Dopeso H; Chen H; Yang J; Wang X; Zhang C; Zhang H
bioRxiv; 2023 May; ():. PubMed ID: 37398114
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p.
Zhao J; Zeng XB; Zhang HY; Xiang JW; Liu YS
Open Med (Wars); 2020; 15(1):921-931. PubMed ID: 33336050
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of FOXK2 in cancers and metabolic disorders.
Xing X; Que X; Zheng S; Wang S; Song Q; Yao Y; Zhang P
Front Oncol; 2024; 14():1376496. PubMed ID: 38741782
[TBL] [Abstract][Full Text] [Related]
18. FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.
Shan L; Zhou X; Liu X; Wang Y; Su D; Hou Y; Yu N; Yang C; Liu B; Gao J; Duan Y; Yang J; Li W; Liang J; Sun L; Chen K; Xuan C; Shi L; Wang Y; Shang Y
Cancer Cell; 2016 Nov; 30(5):708-722. PubMed ID: 27773593
[TBL] [Abstract][Full Text] [Related]
19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
20. FOXK2 transcription factor and its roles in tumorigenesis (Review).
Wang Z; Liu X; Wang Z; Hu Z
Oncol Lett; 2022 Dec; 24(6):461. PubMed ID: 36380871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
